[1]
Rischin, D., Khushalani, N., Schmults, C., Guminski, A., Chang, A.L., Lewis, K., Lim, A., Hernandez-Aya, L., Hughes, B., Schadendorf, D., Hauschild, A., Stankevich, E., Booth, J., Yoo, S.-Y., Chen, Z., Okoye, E., Lowy, I., Fury, M. and Migden, M. 2020. Phase 2 Study of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Longer Follow-Up. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s124. DOI:https://doi.org/10.25251/skin.4.supp.124.